EarningsQ2 2024 Earnings Report

BeOne Medicines (49BA) Q2 2024 Earnings Report

4 Followers

DE:49BA Q2 2024 EPS Results

Actual EPS-€1.03

Consensus EPS-€1.95

Beat/MissBeat by +€0.93

One Year Ago EPS-€3.25

Actual Revenue€828.22M

Expected Revenue€723.15M

Beat/MissBeat by +€105.08M

YoY Revenue Growth+57.70%

QuarterQ2 2024

Date08/26/2024

TimeAfter Close

Conference CallMonday, August 26, 2024

DE:49BA Upcoming Earnings

BeOne Medicines's next earnings date is estimated for November 6, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 06, 2026	2026 (Q3)	1.70 / -	0.973	―
Aug 05, 2026	2026 (Q2)	1.48 / 1.83	0.812	125.27% (+1.02)
May 06, 2026	2026 (Q1)	0.86 / 1.75	0	―
Feb 26, 2026	2025 (Q4)	1.11 / 0.54	-1.276	141.96% (+1.81)
Nov 06, 2025	2025 (Q3)	0.76 / 0.97	-1.026	194.78% (+2.00)
Aug 06, 2025	2025 (Q2)	0.35 / 0.81	-1.026	179.13% (+1.84)
May 07, 2025	2025 (Q1)	-0.51 / 0.00	-2.151	―
Feb 27, 2025	2024 (Q4)	-0.90 / -1.28	-3.15	59.49% (+1.87)
Nov 12, 2024	2024 (Q3)	-0.99 / -1.03	1.794	-157.21% (-2.82)
Aug 26, 2024	2024 (Q2)	-1.95 / -1.03	-3.248	68.41% (+2.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed